Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms
NCT ID: NCT04356586
Last Updated: 2020-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
287 participants
OBSERVATIONAL
2020-05-04
2020-08-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
NCT04370119
Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19)
NCT04425759
Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19
NCT05128656
Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations
NCT05667597
COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020
NCT04723290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jessa Hospital
OTHER
Sciensano
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Gpossens
Scientific collaborator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Goossens, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sciensano
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sciensano
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jessa300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.